IL146917A0 - Composition containing angiotensin ii antagonist, boric acid and ethylenediamine tetraacetic acid - Google Patents

Composition containing angiotensin ii antagonist, boric acid and ethylenediamine tetraacetic acid

Info

Publication number
IL146917A0
IL146917A0 IL14691700A IL14691700A IL146917A0 IL 146917 A0 IL146917 A0 IL 146917A0 IL 14691700 A IL14691700 A IL 14691700A IL 14691700 A IL14691700 A IL 14691700A IL 146917 A0 IL146917 A0 IL 146917A0
Authority
IL
Israel
Prior art keywords
antagonist
ethylenediamine tetraacetic
acid
composition containing
boric acid
Prior art date
Application number
IL14691700A
Other languages
English (en)
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of IL146917A0 publication Critical patent/IL146917A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
IL14691700A 1999-06-11 2000-06-09 Composition containing angiotensin ii antagonist, boric acid and ethylenediamine tetraacetic acid IL146917A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP16494599 1999-06-11
PCT/JP2000/003779 WO2000076543A1 (fr) 1999-06-11 2000-06-09 Composition permettant de reduire la tension oculaire et destinee a l'administration topique

Publications (1)

Publication Number Publication Date
IL146917A0 true IL146917A0 (en) 2002-08-14

Family

ID=15802847

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14691700A IL146917A0 (en) 1999-06-11 2000-06-09 Composition containing angiotensin ii antagonist, boric acid and ethylenediamine tetraacetic acid
IL146917A IL146917A (en) 1999-06-11 2001-12-04 Preparation containing angiotensin II antagonist, boric acid and ethylindiamine tetraacitic acid

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL146917A IL146917A (en) 1999-06-11 2001-12-04 Preparation containing angiotensin II antagonist, boric acid and ethylindiamine tetraacitic acid

Country Status (24)

Country Link
US (1) US6777436B2 (hu)
EP (1) EP1186302B1 (hu)
KR (1) KR100611543B1 (hu)
CN (1) CN1198650C (hu)
AT (1) ATE295721T1 (hu)
AU (1) AU759513B2 (hu)
BR (1) BR0011477A (hu)
CA (1) CA2376780C (hu)
CZ (1) CZ300553B6 (hu)
DE (1) DE60020230T2 (hu)
ES (1) ES2242619T3 (hu)
HK (1) HK1042050A1 (hu)
HU (1) HUP0201466A3 (hu)
IL (2) IL146917A0 (hu)
MX (1) MXPA01012752A (hu)
NO (1) NO328211B1 (hu)
NZ (1) NZ516033A (hu)
PL (1) PL200009B1 (hu)
PT (1) PT1186302E (hu)
RU (1) RU2227740C2 (hu)
TR (1) TR200103603T2 (hu)
TW (1) TWI245639B (hu)
WO (1) WO2000076543A1 (hu)
ZA (1) ZA200109943B (hu)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI290470B (en) * 1999-12-01 2007-12-01 Sankyo Co The composition for treating glaucoma
TW200304812A (en) * 2002-03-08 2003-10-16 Sankyo Co An eye drop containing a tetrazole derivative
US20050119299A1 (en) * 2002-03-08 2005-06-02 Sankyo Company, Limited Ophthalmic solutions containing tetrazole derivatives
US20090042962A1 (en) * 2005-04-21 2009-02-12 Santen Pharmaceutical Co., Ltd. Therapeutic Agent for Keratoconjunctival Disorder
DK2227213T3 (da) * 2007-11-30 2013-01-02 Toltec Pharmaceuticals Llc Sammensætninger og fremgangsmåder til behandling af vaginale infektioner og patogene, vaginle biofilm

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991015206A1 (en) * 1990-04-05 1991-10-17 E.I. Du Pont De Nemours And Company Treatment of glaucoma and ocular hypertension with imidazole angiotensin-ii receptor antagonists
CZ154994A3 (en) * 1993-07-02 1995-09-13 Senju Pharma Co Visual hypotensive agent
EP0743852B1 (en) * 1994-02-08 2005-07-27 Novartis AG Treatment of normotensive glaucoma with valsartan
NZ282485A (en) * 1994-03-16 1997-06-24 Sankyo Co Treatment of ocular hypertension using imidazole derivatives
JPH07324034A (ja) * 1994-05-30 1995-12-12 Toa Yakuhin Kk フマル酸ケトチフェン含有の点眼剤

Also Published As

Publication number Publication date
AU759513B2 (en) 2003-04-17
HK1042050A1 (en) 2002-08-02
ATE295721T1 (de) 2005-06-15
EP1186302A1 (en) 2002-03-13
US6777436B2 (en) 2004-08-17
ZA200109943B (en) 2003-03-03
PL352161A1 (en) 2003-07-28
DE60020230T2 (de) 2006-03-09
TR200103603T2 (tr) 2002-05-21
CA2376780C (en) 2008-05-06
CN1198650C (zh) 2005-04-27
EP1186302A4 (en) 2004-03-24
PT1186302E (pt) 2005-07-29
WO2000076543A1 (fr) 2000-12-21
NO20016023L (no) 2002-01-29
CN1368889A (zh) 2002-09-11
AU5108600A (en) 2001-01-02
CA2376780A1 (en) 2000-12-21
IL146917A (en) 2006-10-31
RU2227740C2 (ru) 2004-04-27
CZ300553B6 (cs) 2009-06-17
US20020147211A1 (en) 2002-10-10
TWI245639B (en) 2005-12-21
BR0011477A (pt) 2002-03-19
KR20020015343A (ko) 2002-02-27
NO328211B1 (no) 2010-01-11
DE60020230D1 (de) 2005-06-23
NZ516033A (en) 2003-09-26
HUP0201466A3 (en) 2003-04-28
MXPA01012752A (es) 2002-07-02
NO20016023D0 (no) 2001-12-10
EP1186302B1 (en) 2005-05-18
ES2242619T3 (es) 2005-11-16
CZ20014415A3 (cs) 2002-04-17
KR100611543B1 (ko) 2006-08-10
PL200009B1 (pl) 2008-11-28
HUP0201466A2 (en) 2002-09-28

Similar Documents

Publication Publication Date Title
NO2013002I1 (no) Aklidinium haogenid (Aklidinium bromid)
MX9700696A (es) Compuestos heterociclicos, utiles como productores de efecto aloesterico en receptores muscarinicos.
AU7833698A (en) Compounds with combined antihistaminic and mast cell stabilizing activities, intended for ophthalmic use
AU6103000A (en) Compounds with activity on muscarinic receptors
AU6243690A (en) One piece channel suture package
AU5557800A (en) Thieno- and furopyrimidine derivatives as a2a-receptor antagonists
CA2198535A1 (en) Method of increasing testosterone
AU2859700A (en) Overhead storage device
TW595806U (en) Tape carrier
AU6440600A (en) Combination of active agents, said combination containing clonidine
ZA953673B (en) Stable crystalline (6S)- and (6R)- tetrahydrofolic acid
AU4301596A (en) Transdermal preparation containing a loratidine metabolite with antihistaminic activity
MXPA03007261A (es) Moduladores del receptor de glucocorticoides.
IL146917A0 (en) Composition containing angiotensin ii antagonist, boric acid and ethylenediamine tetraacetic acid
NZ307159A (en) Medicament containing tiagabine, antioxidant, and carrier
AU7887300A (en) Buffered phosphorus containing solution
ZA986130B (en) Highly pure ciprofloxacin infusion solutions
TW356416B (en) Stabilized agrochemical composition containing 1-(2-chloroimidazolo[1,2-a]pyrid-3-ylsulfonyl)-3-[4,6-dimethylpyrimid-2-yl]urea or its salts
AU5318698A (en) New imidazopyridines and oxazolopyridines
AU3974997A (en) Thrombin inhibitors
AU100551S (en) Disposable lighter package
AU3268501A (en) Holder for securing one or more batteries
AU8136494A (en) Equidae manure/urine catcher
AU98276S (en) Drill press
KR0108088Y1 (en) Holder for battery package

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed